The global post-operative nausea and vomiting (PONV) market was valued at US$ 2.1 Bn in 2022 and is expected to expand at a CAGR of 7.4% from 2023 to 2031, reaching US$ 4.0 Bn by the end of 2031. The market is experiencing significant growth as healthcare providers increasingly focus on improving patient outcomes and enhancing post-surgical recovery experiences. PONV remains one of the most common complications following anesthesia and surgical procedures, affecting millions of patients worldwide each year. The growing emphasis on patient-centered care, advancements in antiemetic therapies, and increasing surgical volumes across healthcare systems are contributing to the sustained expansion of this market.

Access key findings and insights from our Report in this sample – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2969

Market Overview

The post-operative nausea and vomiting market plays a critical role in modern perioperative care. PONV is a common adverse effect associated with anesthesia and surgical interventions, often resulting in patient discomfort, prolonged hospital stays, delayed recovery, and increased healthcare costs. As healthcare systems continue to prioritize enhanced recovery after surgery (ERAS) protocols, preventing and managing PONV has become a major clinical objective. The development of novel antiemetic drugs, combination therapies, and targeted treatment approaches has significantly improved prevention and management strategies. Furthermore, growing awareness among healthcare professionals regarding the importance of PONV prevention is driving the adoption of advanced therapeutic solutions across hospitals, ambulatory surgical centers, and specialty clinics.

Market Size and Growth

The PONV market size stood at US$ 2.1 Bn in 2022 and is projected to reach US$ 4.0 Bn by 2031, reflecting a CAGR of 7.4% during the forecast period. This growth is primarily driven by the increasing number of surgical procedures performed globally, fueled by aging populations, rising prevalence of chronic diseases, and expanding access to healthcare services. Technological advancements in surgical techniques, including minimally invasive procedures, are also contributing to market demand as healthcare providers seek comprehensive recovery solutions. Additionally, the growing adoption of multimodal antiemetic therapies and the introduction of innovative drug formulations are creating new growth opportunities for market participants. Increasing healthcare expenditure and favorable reimbursement policies in developed regions are further supporting market expansion.

Market Segmentation

The post-operative nausea and vomiting market can be segmented based on drug class, route of administration, end-user, and distribution channel. By drug class, the market includes serotonin antagonists, dopamine antagonists, neurokinin-1 receptor antagonists, corticosteroids, antihistamines, and combination therapies. Serotonin antagonists continue to hold a significant market share due to their established efficacy and widespread clinical use. Based on route of administration, the market is divided into oral, injectable, and transdermal formulations, with injectable therapies dominating in hospital settings. End-users include hospitals, ambulatory surgical centers, and specialty clinics, while distribution channels encompass hospital pharmacies, retail pharmacies, and online pharmacies. The increasing demand for personalized treatment regimens is expected to influence future market segmentation trends.

Regional Analysis

North America currently dominates the global PONV market due to its advanced healthcare infrastructure, high surgical procedure volumes, and strong adoption of innovative antiemetic therapies. The presence of leading pharmaceutical companies and ongoing clinical research activities further strengthen the region's market position. Europe represents another significant market, supported by growing healthcare investments and increasing awareness regarding postoperative care quality. Meanwhile, Asia-Pacific is expected to witness the fastest growth during the forecast period, driven by expanding healthcare access, rising healthcare expenditure, and increasing surgical interventions in countries such as China, India, and Japan. Latin America and the Middle East & Africa are also showing promising growth potential as healthcare infrastructure continues to improve.

Competitive Landscape

According to the latest post-operative nausea and vomiting market insights, the global market is highly competitive, with significant participation from both domestic and international players. The market report highlights strategies that can support new entrants in establishing a presence while enabling existing participants to strengthen their distribution networks and expand geographic reach. Key companies operating in the market include Acacia Pharma, F. Hoffmann-La Roche AG, Novartis AG, Ani Pharmaceuticals, Inc., Camurus AB, Sanofi S.A., Helsinn Holding S.A., Eisai Corporation, GlaxoSmithKline Corporation, and Merck and Co. These companies are focusing on research and development, strategic partnerships, product innovation, and regulatory approvals to enhance their competitive positions and address evolving clinical needs.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Media Contact: 

Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY - 12207, United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453